United States Food and Drug Administration
PulseAugur coverage of United States Food and Drug Administration — every cluster mentioning United States Food and Drug Administration across labs, papers, and developer communities, ranked by signal.
- parent of Center for Drug Evaluation and Research 100%
- subsidiary of United States Department of Health and Human Services 100%
- employed by Marty Makary 95%
- employed by Kyle Diamantas 90%
- other Supreme Court of the United States 60%
- affiliated with Biden Administration 60%
- affiliated with Joe Biden Administration cabinet 60%
- other Marty Makary 60%
- 2026-05-23 regulatory The FDA published new guidelines allowing certain e-cigarettes and nicotine pouches onto the market without full regulatory vetting. 来源
- 2026-05-19 product_launch The FDA approved the first gene therapy for deafness. 来源
- 2026-05-18 hiring Marty Makary has departed as FDA commissioner, leading to a change in leadership at the agency. 来源
- 2026-05-16 hiring Dr. Tracy Beth Hoeg was removed from her role as acting director of the FDA's drug program and replaced by Dr. Mike Davis. 来源
- 2026-05-15 regulatory The FDA is preparing to issue alerts regarding AI hallucinations in healthcare by 2026. 来源
- 2026-05-15 regulatory The FDA eased restrictions on certain vaping products and reconsidered a ban on minors using tanning beds. 来源
- 2026-05-12 hiring US Food and Drug Commissioner Marty Makary resigned, with Kyle Diamantas stepping in as acting head. 来源
- 2026-05-12 hiring FDA Commissioner Marty Makary is stepping down after a turbulent 13-month term. 来源
- 2026-05-12 hiring FDA Commissioner Marty Makary resigned after a tumultuous 13-month tenure. 来源
14 天有情绪数据
-
Food dye bans offer illusion of health, not real dietary change
Removing artificial food dyes will not significantly improve American diets, despite widespread public support for such changes. Consumers often express a desire for cleaner ingredients but continue to purchase products…
-
Lin Junyan launches AI firm at $2B valuation; FDA approves diabetes drug raw material
Lin Junyan has launched a new company that has achieved a valuation of approximately $2 billion. The company is focused on the emerging field of AI. Separately, Tonghe Pharmaceutical received FDA approval for its Kaglie…
-
Pharma leaders seek stable FDA amid pricing policy concerns
Pharmaceutical industry leaders are advocating for stability and predictability from the next Food and Drug Administration (FDA) commissioner following a period of leadership changes and uncertainty. CEOs from major dru…
-
Digital twins proposed as synthetic controls for clinical trials
Researchers have published a paper detailing the use of digital twins as synthetic control arms in single-arm clinical trials. These advanced machine learning models can generate personalized predictions of disease prog…
-
US Food and Drug Commissioner Marty Makary resigns amid Republican pressure
US Food and Drug Commissioner Marty Makary has resigned following significant pressure from Republican lawmakers and anti-abortion groups. President Donald Trump announced Makary's departure, stating he was "having some…
-
FDA Commissioner Marty Makary Resigns Amidst Controversy and Upheaval
FDA Commissioner Dr. Marty Makary has resigned after a turbulent 13-month tenure marked by organizational upheaval and controversies. His initiatives to streamline drug approvals and increase transparency faced criticis…
-
US debates AI policy, FDA advances AI in clinical trials
The US is experiencing a policy divide regarding artificial intelligence, with the FDA actively promoting AI for clinical trials. Meanwhile, discussions are ongoing about access to frontier AI models, highlighting a bro…
-
开源工具赋予AI完全访问制药研发数据的权限
一个名为drug-pipeline-mcp的开源项目已发布，为AI代理提供对制药研发数据的全面访问。该工具聚合了临床试验、FDA/EMA批准、安全报告、药品标签、专利到期、召回和PubMed出版物的信息。该项目旨在为AI提供对药物开发管线的深入见解，能够进行诸如“Novo Nordisk的管线中有哪些？”之类的查询。该计划已获得MIT许可，并在GitHub上可用。
-
WHOOP融资5.75亿美元，估值101亿美元，目标是转型为健康平台
WHOOP，一家以健身可穿戴设备闻名的公司，已在G轮融资中获得5.75亿美元，估值达到101亿美元。本轮融资得到了医疗健康巨头Abbott和Mayo Clinic的战略投资，标志着WHOOP正从一个面向消费者的健康品牌转型为一个全面的个人健康平台。该公司正在将其订阅服务中整合更多临床功能，如FDA批准的心电图监测和先进的生物标志物测试，目标是成为个人健康管理的核心枢纽。
-
FDA 局长 Marty Makary 的未来因政治剧动而不明朗
美国食品药品监督管理局（FDA）正经历内部动荡，围绕局长 Marty Makary 的潜在解职展开。有报道称 Makary 将被解雇，但他似乎得以幸免，尽管其职位仍不明朗。FDA 监管着美国经济的相当一部分，这种不稳定可能会导致政策和行业运营的中断。
-
AI/ML studies surge in high-income countries, focus on neoplasms
A recent analysis of AI/ML studies conducted between 2010 and 2023 reveals a significant growth trend, particularly in high-income nations. Out of 3,106 studies examined, a notable portion were FDA-regulated (7.6%) and …
-
Right to Try laws fail to provide patient access to unapproved drugs
The "Right to Try" and FDA's Expanded Access pathways are intended to allow patients with severe illnesses to access unapproved treatments. However, these programs are rarely utilized because biotech companies, which fu…
-
Gates Foundation funds Kanvas Biosciences' AI-driven microbiome pill for malnutrition
Kanvas Biosciences has secured funding from the Bill & Melinda Gates Foundation to develop a novel treatment for environmental enteric dysfunction (EED), a disease affecting millions of children globally. The startup is…
-
Databricks Genie tool accelerates RWE analysis for medical affairs
Databricks has introduced a new tool called Genie for Medical Affairs Intelligence, designed to address the "RWE Fluency Gap" in the life sciences industry. This tool allows medical affairs leaders to query complex real…
-
DIY electrolysis machine offers permanent hair removal; Amazon Luna adds new games
This cluster contains two unrelated news items. The first discusses a DIY electrolysis machine for permanent hair removal, referencing the FDA's classification of electrolysis as the sole permanent method. The second it…
-
Neuralink develops surgical robot for brain access, aims for universal neural interface
Neuralink is developing a surgical robot designed to access any part of the brain. The company aims to create a universal neural interface to treat brain-related conditions. This device is currently in the research phas…
-
Anthropic CEO warns of AI-driven software bankruptcies, opposes strict regulation
Anthropic CEO Dario Amodei predicts that AI will lead to widespread software bankruptcies as the technology automates many existing coding tasks. He argues against strict, FDA-style regulation for AI, suggesting it coul…
-
FDA launches updated AI data platform; research shows women in AI-vulnerable jobs
The U.S. Food and Drug Administration (FDA) has introduced an updated data platform that incorporates artificial intelligence. Concurrently, new research indicates that women are disproportionately employed in jobs that…
-
分析发现，防晒霜每两小时重新涂抹一次的规定缺乏科学证据
在阳光下每两小时重新涂抹一次防晒霜的常见指南并非基于强有力的科学证据。这一建议似乎源于FDA在2007年提出的一项规定，该规定引用了研究和公共卫生声明。然而，对所引用的证据的审查，包括Wright等人2001年的一项研究，揭示了其基础薄弱，样本量小且方法学可疑。FDA在2011年发布的最终规定维持了每两小时涂抹一次的指南，声称数据支持该指南，但基础研究仍然薄弱。
-
AI健康硬件公司山木科技完成近1400万美元融资，用于持续健康监测
AI原生健康硬件公司山木科技已完成近1亿元人民币的A轮融资，由溪石资本领投，现有投资者参与。该公司计划利用这笔资金推出其面向消费者的医疗产品、完成B2B定制模块交付，并寻求国际医疗认证。山木科技的创新方法是将医疗级设备融入日常生活，例如安装在马桶上的分析仪，可持续收集尿液、唾液和汗液样本，用于AI驱动的健康监测和干预。